B. pertussis expresses a number of proteins including the 69K OMP, (pertactin) filamentous hemagglutinin, and pertussis toxin that may promote adherence of B. pertussis to mammalian cells. In order to study the potential role of these proteins in bacterial adherence mutants specifically lacking pertactin, FHA or pertussis toxin are being constructed using the pertussis suicide vector pRTP1. Through the use of antibiotic resistance markers and double recombination events mutants deficient in the expression of pertactin, FHA or both proteins have been constructed and characterized. A decrease in adherence to mammalian cell lines is seen with all the mutants, with the mutant lacking both proteins demonstrating a synergistic effect. Mutants lacking pertussis toxin or all virulent associated proteins are presently being constructed in order to assess the contribution of other bacterial proteins to adhesion.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BA007015-02
Application #
3811014
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost